Abstract:Rationale Lipid rafts are detergent-insoluble plasma membrane microdomains implicated in membrane signaling and trafficking. We have demonstrated that the lysophospholipid sphingosine 1-phosphate (S1P) plays a critical regulatory role in the maintenance and enhancement of pulmonary vascular barrier function, which is dependent on lipid raft-mediated signaling events (Singleton et al. FASEB J 2005). In this study, we used two-dimensional electrophoresis analysis to determine the protein profiles in S1P-challenged lipid rafts of human pulmonary artery endothelial cells (HPAECs). Methods and Results HPAECs were treated with S1P (1 μM) for 5 minutes and solubilized with 1% Triton X-100 at 4°C. The Triton X-100 insoluble and light density fractions were collected after discontinuous OptiprepTM gradient centrifugation. The isolated lipid rafts pellets were resolubilized in 50 μL of isoelectric focusing (IEF) buffer (7 M urea/2 M thiourea, 4% CHAPS). IEF was carried out on a linear electrophoresis gel strip (pH 3-10, 7 cm), with the second dimension performed on 4 to 20% SDS-PAGE gel. Analytic gels were stained using Imperial blue (Pierce). We observed several novel protein bands in lipid rafts isolated from S1P versus control-treated cells (1 μM, 5 minutes). To identify these novel proteins, analytic gels were stained with Sypro Ruby and images were analyzed using PDQuest (Bio-Rad). Novel protein spots were sliced from the gel, and gel pieces were swelled in 20 ng/μL modified trypsin and incubated at 37°C overnight after protein reduction and alkylation. The digested peptides were extracted with 5% formic acid and 50% acetonitrile. Protein identification was performed on ABI 4700 Maldi TOF/TOF MS. Two-dimensional gel image analysis results indicated that about 50 protein spots (such as discoidin domain receptor tyrosine kinase, myosin light chain kinase, pp60src, phosphodiesterase 6C, etc.) have over a threefold change after S1P (1 μM, 5 minutes) treatment compared with control. Further, antiphosphotyrosine immunoblots of two-dimensional gels indicated that S1P increased tyrosine phosphorylation of over 20 proteins, including the actin regulatory protein cortactin. Conclusions Taken together, these results indicate that S1P induces recruitment of novel tyrosine kinases (ie, discoidin domain receptor tyrosine kinase, pp60src), with multiple tyrosine phosphorylation events in lipid rafts. These results suggest that recruitment of tyrosine kinases to lipid rafts may participate in S1P-induced signaling in HPAECs and could potentially play important roles in regulating S1P-induced pulmonary endothelial cells barrier function.

Proteome Analysis of Sphingosine 1-Phosphate-mediated Lipid Rafts in Human Pulmonary Endothelial Cells.

72 PROTEOME ANALYSIS OF SPHINGOSINE 1-PHOSPHATE-MEDIATED LIPID RAFTS IN HUMAN PULMONARY ENDOTHELIAL CELLS.

Single-Cell Transcriptomics Reveals the Difference of Aortic Atherosclerosis Response to Phytosterols and Oxidation Products of Sterols.

Sphingosine 1-phosphate-regulated transcriptomes in heterogenous arterial and lymphatic endothelium of the aorta

Point-Counterpoint of Sphingosine 1-Phosphate Metabolism

A Pipeline to Investigate the Structures and Signaling Pathways of Sphingosine 1-Phosphate Receptors

Sphingolipids control dermal fibroblast heterogeneity

Elevating Endogenous Sphingosine-1-Phosphate (S1P) Levels Improves Endothelial Function and Ameliorates Atherosclerosis in Low Density Lipoprotein Receptor-Deficient (LDL-R−/−) Mice

Direct Chemical Evidence for Sphingolipid Domains in the Plasma Membranes of Fibroblasts.

Sphingosine 1-phosphate and its regulatory role in vascular endothelial cells

Proteomic Profile Of Alveolar Type Ii Cell Lipid Rafts: Identification Of Novel Proteins Involved In Lung Surfactant Secretion.

Proteomic characterization of human early pro-angiogenic cells

Emerging biology of sphingosine-1-phosphate: its role in pathogenesis and therapy.

Sphingosine-1-phosphate Signaling Pathway: a Novel Therapeutic Target for Cardiovascular Diseases

Abstract 14880: Single-cell Transcriptomes Identify Unique Endothelial Subpopulation (FABP4 + TMEM100 - ) With Lipid Metabolism Dysfunction in Pulmonary Arterial Hypertension

The Balance Between Gαi-Cdc42/Rac and Gα12/13-RhoA Pathways Determines Endothelial Barrier Regulation by Sphingosine-1-phosphate

Molecular basis of Spns2-facilitated sphingosine-1-phosphate transport

Abstract 20527: Nrf2 Signaling Modulates Human Endothelial Cell Barrier Regulation by S1P

Rewiring Endothelial Sphingolipid Metabolism to Favor S1P Over Ceramide Protects From Coronary Atherosclerosis

Effect of the sphingosine kinase 1 selective inhibitor, PF-543 on arterial and cardiac remodelling in a hypoxic model of pulmonary arterial hypertension

Effect of Sphingosine 1-Phosphate (S1P) on Proliferation of Human Fetal Lung Fibroblasts